[New model of the optimal oral antiplatelet treatment in patients with the ST-segment elevation myocardial infarction in Poland - authors' reply]

Kardiol Pol. 2012;70(3):317-20.
[Article in Polish]
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / therapy*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Purinergic P2Y Receptor Antagonists / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists